MyAverix Finance
F · Healthcare
INNATE PHARMA SP.ADR/1 (IDDA)
Biotechnology
INNATE PHARMA SP.ADR/1 (IDDA) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $159.64M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for IDDA
INNATE PHARMA SP.ADR/1 (IDDA) — FAQ
What is INNATE PHARMA SP.ADR/1's market cap?
INNATE PHARMA SP.ADR/1 (IDDA) has a reported market cap of $159.64M (data as of 2026-05-22).
What is IDDA's P/E ratio?
The price-to-earnings (P/E) ratio for INNATE PHARMA SP.ADR/1 (IDDA) is 25.00 (data as of 2026-05-22).
Does INNATE PHARMA SP.ADR/1 pay a dividend?
Dividend yield is not available in the current snapshot for INNATE PHARMA SP.ADR/1 (IDDA). Check the MyAverix Finance app for the latest dividend data.
What sector is INNATE PHARMA SP.ADR/1 in?
INNATE PHARMA SP.ADR/1 (IDDA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is IDDA listed on?
IDDA is listed on F.
What is INNATE PHARMA SP.ADR/1's net margin?
INNATE PHARMA SP.ADR/1 (IDDA) reports a net margin of 0.0% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.